Abstract
Tic, short for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, is a kind of unnatural α-amino acids. Due to its distinct geometrical conformation and biological activity, the structure of Tic, regarded as the surrogate of proline and the rigid analogue of phenylalanine or tyrosine, has been introduced into many compounds, which target diverse enzymes or receptors. The most successful example is that substituting the Tic residue for the proline residue of enalapril led to an approved drug quinapril. In this review, we will summarize the applications and modifications of Tic in peptides and peptidomimetics design and discovery, and hope to spark medicinal researchers inspiration in the field of protein and peptide drug design and optimization.
Keywords: 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), opioid ligands, farnesyl transferase inhibitors, integrin antagonists, angiotensin-converting enzyme inhibitors, prolyl endopeptidases inhibitors, endogenous mammalian, opiod receptor antagonists, linker, anxiety, depression, schizophrenia, addiction, eating disorders, glycoprotein receptors, immunosupressant
Current Protein & Peptide Science
Title: Applications and Modifications of 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) in Peptides and Peptidomimetics Design and Discovery
Volume: 11 Issue: 8
Author(s): Yingjie Zhang, Hao Fang and Wenfang Xu
Affiliation:
Keywords: 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), opioid ligands, farnesyl transferase inhibitors, integrin antagonists, angiotensin-converting enzyme inhibitors, prolyl endopeptidases inhibitors, endogenous mammalian, opiod receptor antagonists, linker, anxiety, depression, schizophrenia, addiction, eating disorders, glycoprotein receptors, immunosupressant
Abstract: Tic, short for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, is a kind of unnatural α-amino acids. Due to its distinct geometrical conformation and biological activity, the structure of Tic, regarded as the surrogate of proline and the rigid analogue of phenylalanine or tyrosine, has been introduced into many compounds, which target diverse enzymes or receptors. The most successful example is that substituting the Tic residue for the proline residue of enalapril led to an approved drug quinapril. In this review, we will summarize the applications and modifications of Tic in peptides and peptidomimetics design and discovery, and hope to spark medicinal researchers inspiration in the field of protein and peptide drug design and optimization.
Export Options
About this article
Cite this article as:
Zhang Yingjie, Fang Hao and Xu Wenfang, Applications and Modifications of 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) in Peptides and Peptidomimetics Design and Discovery, Current Protein & Peptide Science 2010; 11(8) . https://dx.doi.org/10.2174/138920310794557691
DOI https://dx.doi.org/10.2174/138920310794557691 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria
Current Hypertension Reviews Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction?
Current Diabetes Reviews Revisiting the J-curve Phenomenon. An Old New Concept?
Current Hypertension Reviews Drug Interactions of Tipranavir, a New HIV Protease Inhibitor
Drug Metabolism Letters Intrathecal Apelin-13 Produced Different Actions in Formalin Test and Tail-flick Test in Mice
Protein & Peptide Letters Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium
Current Pediatric Reviews Fospropofol, A New Sedative Anesthetic, and Its Utility in the Perioperative Period
Current Pharmaceutical Design Adrenomedullins: Therapeutic Potential in Cardiovascular Disease
Current Hypertension Reviews Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design Oleic Acid in Olive Oil: From a Metabolic Framework Toward a Clinical Perspective
Current Pharmaceutical Design Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis
Current Vascular Pharmacology Heteroaromatization with 4-Phenyldiazenyl-1-naphthol. Part IV: Synthesis of Some New Heterocyclic Compounds with Potential Biological Activity
Current Organic Synthesis The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Clinical Cancer Drugs Vitamin D Measurement in the Intensive Care Unit: Methodology, Clinical Relevance and Interpretation of a Random Value
Inflammation & Allergy - Drug Targets (Discontinued)